VivoSim Labs, Inc. (LON:0R02)
0.2645
+0.0054 (2.08%)
Mar 20, 2025, 5:32 PM BST
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of 3.75 million as of December 24, 2025. Its market cap has decreased by -32.18% in one year.
Market Cap
3.75M
Enterprise Value
-419.47K
Revenue
104.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from 36.80M to 3.75M, a decrease of -89.80%. That is a compound annual growth rate of -15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 3.75M | -33.52% |
| Dec 31, 2024 | 5.64M | -33.94% |
| Dec 29, 2023 | 8.55M | -16.20% |
| Dec 30, 2022 | 10.20M | -56.31% |
| Dec 31, 2021 | 23.34M | -61.52% |
| Dec 31, 2020 | 60.65M | 73.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 211.39B |
| GSK plc | 72.63B |
| Haleon | 33.05B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.71B |
| Hikma Pharmaceuticals | 3.37B |
| Genus | 1.72B |
| HUTCHMED (China) | 1.70B |